222973-62-8

Upstream product

• 91-09-8 methyl β-L-arabinopyranoside 
• 38088-60-7 methyl 3,4-O-isopropylidene-β-L-arabinopyranoside 
• 98-88-4 benzoyl chloride 

Downstream Products

• 222973-59-3 methyl 2,3-di-O-benzoyl-4-deoxy-4-<(1R,4R,5S,6S)-4,5,6-tribenzyloxycyclohex-2-en-1-yl>amino-β-D-xylopyranoside 
• 222973-63-9 methyl 2,3-di-O-benzoyl-4-deoxy-4-<(1R,4R,5S,6R)-4,5,6-tribenzyloxycyclohex-2-en-1-yl>thio-β-D-xylopyranoside 
• 222973-58-2 methyl 2,3-di-O-benzoyl-β-L-arabinopyranozide 
• 101242-41-5 methyl 2,3-di-O-benzoyl-4-O-trifluoromethylsulfonyl-α-L-arabinopyranoside 

Relevant academic research and scientific papers

Conformational equilibria of methyl α-L-arabinopyranosides in solution

Experimental NMR studies on methyl α-L-arabinopyranosides in CDCl3, pyridine and dioxane have shown that the equilibria between conformers are displaced in favour of the 4C1 conformer, except in the case of 2-substituted derivatives in CDCl3. The experimental data and a theoretical analysis aimed at explaining them in terms of intramolecular and stereoelectronic solvent effects are presented. It appears that certain electrostatic interactions and the anomeric effect, which favour 1C4 in conformational equilibria are particularly important in 2-substituted derivatives provided no disruption of intramolecular H-bridges takes place. This explains the experimental findings and throws further light on the interplay of effects which determine conformational equilibria in solution.

A synthesis of conduramine B and a 'condurithiol', useful molecules for studying the inhibition of β-xylosidases

Conduramine B and a 'condurithiol', namely (1S,2S,3R,6R)-6-aminocyclohex-4-ene-1,2,3-triol and 1R,2S,3R,6R)-6-sulfanylcyclohex-4-ene-1,2,3-triol, have been prepared by the thermal rearrangement of an acetimidate and a dithiocarbonate, respectively. Both the amine and the thiol are putative inhibitors of β-xylosidases and, in order to mimic the natural substrate more closely, an N- and an S-pseudo-disaccharide have been prepared.